Managing Intellectual Capital Assets
Novel models of collaboration including pre-discovery consortia, R&D networks, centers of excellence, public-private partnerships, crowd-sourcing and web-based collaboration platforms are increasingly being sought for drug discovery and development activities. The opportunity to employ these emerging models of open innovation is not only determined by organizational structure and size, but equivalently by the goals of the endeavor namely—knowledge creation, dissemination, shared governance of intellectual assets, and the engagement of human capital across organizational boundaries.
A framework is developed in this article to consider the dimensions of partnerships from the perspective of intellectual capital assets. The length of partnerships and consequently the goals of knowledge creation as well as the degree of openness to participation and knowledge sharing are discussed as the initial two dimensions. A third dimension is then added namely--the complexity of the partnership with a role in the management of human capital.
The framework developed in this paper categorizes potential partnerships along these three dimensions, offers examples and then suggests lessons to be learned. As new participants emerge in the drug discovery process, expectations regarding knowledge creation and dissemination must be well articulated and meet the objectives of participation.